B Lathan - and the German Hodgkin’s Lymphoma Study Group (GHSG), University Hospital Cologne

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 76 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Drug Monitoring Detects Under- and Overdosing in Patients Receiving 5-Fluorouracil-containing Chemotherapy—results of a Prospective, Multicenter German Observational Study

M. Li,S. Mindt,A. Lueck,U. Hutzschenreuter, M. Kollendt,B. Lathan, T. Zoeller, S. Frank-Gleich, C. Lorentz, C. Lamberti, C. Sick, M. Zingerle, H. Tesch, W. Stein,H. Hebart, C. Stosiek,R. Sandner, S. Fries,I. Burkholder,R. -D Hofheinz

ESMO open（2023）

引用1浏览0WOS引用

Results of the 5th interim analysis of the non-interventional MOMENT II-study: efficacy and safety of Nilotinib in newly diagnosed Ph plus CML patients in chronic phase

H. Tesch,B. Lathan,A. Sauer,S. Tebbe,M. Schulze,T. Ulshoefer,E. Lange, A. Nusch, Jaeckle J.,J. Janssen,S. Rupprecht,M. Meincke, T. Tesanovic

ONCOLOGY RESEARCH AND TREATMENT（2017）

引用0浏览0引用

The relevance of the international prognostic scoring system (IPSS) for patients with myelodysplasia (MDS) at higher age

H. T. Steinmetz, R. Wandat, B. Haastert,A. Sauer,B. Lathan,C. Lerchenmueller,H. Tesch,U. Germing,S. Schmitz

ONCOLOGY RESEARCH AND TREATMENT（2016）

引用0浏览0引用

Three years after the start of enrolment: Current data from the prospective CLL-registry of the German CLL Study Group

A. M. Fink,C. Maurer,J. Bahlo, S. Kluth,H. Linde,A. Aldaoud,T. Illmer,J. Dengler,M. Klausmann,B. Lathan,O. Al-Sawaf,K. Fischer,C. -M Wendtner,B. Eichhorst,M. Hallek

ONCOLOGY RESEARCH AND TREATMENT（2016）

引用0浏览0引用

AGE DISTRIBUTION OF PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) IN GERMANY AND THEIR PROGNOSIS ACCORDING TO THE INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS): DATA FROM THE REGULAR CARE MDS REGISTRY

H. T. Steinmetz,I. Boettger, R. Wahdat, B. Haastert,B. Lathan,A. Sauer,U. Germing,S. Schmitz

HAEMATOLOGICA（2016）

引用0浏览0引用

Efficacy and safety of Nilotinib in newly diagnosed Ph plus CML patients in chronic phase: Results of the 4th interim analysis of the non-interventional MOMENT II-study

B. Lathan,A. Sauer,S. Tebbe,T. Ulshoefer,E. Lange,M. Schulze, A. Nusch,J. Janssen,C. Losem,M. Meincke,S. Rupprecht,H. Tesch

ONCOLOGY RESEARCH AND TREATMENTno. SUPnan (2016): 57-57

引用0浏览0引用

Assessment of the myelodysplasia (MDS) international prognostic scoring system (IPSS) in routine care: Data from the regular care MDS registry

T. H. Steinmetz,I Boettger,A. Sauer,B. Lathan,U. Germing,S. Schmitz

ONCOLOGY RESEARCH AND TREATMENTno. SUPnan (2015): 183-183

引用0浏览0引用

Need of transfusions, treatment and survival of patients with Myelodysplastic Syndromes (MDS): Update of the outpatient MDS registry

H. T. Steinmetz,I Boettger,B. Lathan,A. Sauer,K. Severin,U. Germing,S. Schmitz

ONCOLOGY RESEARCH AND TREATMENTno. SUPnan (2014): 234-234

引用0浏览0引用

Interim analysis of the non-interventional MOMENT II study - efficacy and safety of Nilotinib in routine clinical management of newly diagnosed Ph plus CML patients in chronic phase

A. Sauer,B. Lathan,K. Blumenstengel,T. Gabrysiak,S. Tebbe,M. Meincke,O. Frank,H. Tesch

ONCOLOGY RESEARCH AND TREATMENT（2014）

引用0浏览0引用

Results of an interim analysis of the non-interventional MOMENT II-study for determining efficacy and safety of Nilotinib in newly diagnosed Ph plus CML patients in chronic phase

B. Lathan,A. Sauer,S. Tebbe, T. M. Ulshoefer,K. Blumenstengel,T. Gabrysiak,E. Lange,C. Losem,E. Schmidt,M. Meincke,O. Frank,H. Tesch

ONCOLOGY RESEARCH AND TREATMENTno. SUPnan (2014): 63-63

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn